by Market Overview:
Next generation probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host beyond basic nutrition. They include beneficial effects through their action on intestinal and extra-intestinal functions or through immune responses. They are used to treat various intestinal and extra-intestinal conditions such as IBS, IBD, atopic dermatitis, asthma, colic, flu and other infections.
Market Dynamics:
The global next generation probiotics market is witnessing high growth owing to rising health concerns among consumers regarding digestive health and immune system support. According to a study by Pendulum, around 70% of consumers suffer from digestive issues like gas, bloating, constipation or diarrhea, which is propelling the demand for next generation probiotics. Furthermore, the advancements in microbiome science are enabling researchers to develop better defined and more effective probiotic strains to target specific health conditions. For instance, Amsterdam Winclove Probiotics developed the EVectolin range of next generation probiotics containing bacterial strains with proven efficacy against conditions like IBS, antibiotic-associated diarrhea, etc.
Improving distribution networks of key players is another factor fueling the market growth. Companies like Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys and Chr. Hansen Holding A/S have expanded their international presence through strategic collaborations with distributors and retailers across Europe, North America, and Asia Pacific regions. This wider availability of next generation prob
Segment Analysis
The Next Generation Probiotics Market Demand is dominated by the dietary supplements sub segment. This is because the health benefits of probiotic supplements are widely accepted and consumers are gravitating towards preventive healthcare. Probiotic supplements help maintain a balance of gut microflora and enhance digestive health.
PEST Analysis
Political: Regulations regarding probiotic products and their health claims vary across regions. Harmonization of regulations can provide opportunities.
Economic: Rising income levels and health expenditure are driving demand for high-value probiotic products.
Social: Growing health-consciousness is boosting the consumption of probiotic supplements for conditions like IBS and skin health.
Technological: Advancements in microencapsulation and cryoprotection technologies are helping deliver live microbes effectively.
Key Takeaways
The global next generation probiotics market is expected to witness high growth, exhibiting a CAGR of 11.2% over the forecast period, due to increasing awareness about gut and digestive health. North America dominates the market currently due to high consumer awareness and extensive R&D. Clinical studies highlighting the role of probiotics in managing obesity and lowering the risk of certain cancers are expanding the application scope.
Regional analysis
The North American region currently dominates the next generation probiotics market owing to high consumer awareness levels regarding digestive health and gut microbiome. Wide availability of probiotic supplements and live biotherapeutic products containing human-derived strains is supporting market growth here.
Key players
Key players operating in the next generation probiotics market include Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. These players are focusing on new product launches and clinical validations to strengthen their positions in the global market.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
